Besponsa (Inotuzumab ozogamicin ) 0.9 mg Pfizer

World wide shipping

Medicines from all over the world. We will help you find any drug in 24 hours. Prices for medicines are presented for informational purposes only.

ua ru en

Menu

Search for a drug:

Home
Hematology
Besponsa (Inotuzumab ozogamicin ) 0.9 mg Pfizer

Product Catalog

Cart

Cart is empty

Besponsa (Inotuzumab ozogamicin ) 0.9 mg Pfizer - photo

In Stock

0 $

5 000 $

− +

Out of stock

Description

Indications

Inotuzumab ozogamicin is indicated as monotherapy for the treatment of adult patients with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL), including adult patients with Philadelphia chromosome-positive (Ph+) B-cell precursor ALL after failure of therapy with at least one tyrosine kinase inhibitor (TKI).

Features